(Q38750753)

6 September 2017

title

NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations (English)

1 reference

6 September 2017

0 references

1 reference

Justin A MacDonald

3

0 references

Kris Chadee

series ordinal

4

object named as

Kris Chadee

1 reference

6 September 2017

Leanne Mortimer

1

1 reference

6 September 2017

France Moreau

series ordinal

2

1 reference

6 September 2017

language of work or name

English

0 references

publication date

22 August 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

17

1 reference

6 September 2017

issue

10

1 reference

6 September 2017

page(s)

1176-1186

1 reference

An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

6 September 2017

cites work

1 reference

12 December 2020

Prostaglandin E2 Receptor Expression in Fetal Baboon Lung at 0.7 Gestation After Betamethasone Exposure

1 reference

12 December 2020

Resolution of inflammation: the beginning programs the end

1 reference

12 December 2020

Inhibition by 16,16-dimethyl prostaglandin E2 of tumor necrosis factor-alpha and interleukin-1beta production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori

1 reference

12 December 2020

Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling

1 reference

12 December 2020

Inflammasomes in health and disease

1 reference

12 December 2020

Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi

1 reference

12 December 2020

Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling

1 reference

12 December 2020

Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design.

1 reference

12 December 2020

Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.

1 reference

12 December 2020

Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity

1 reference

12 December 2020

Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression

1 reference

12 December 2020

Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB.

1 reference

12 December 2020

Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774

1 reference

12 December 2020

Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation

1 reference

12 December 2020

Twenty year follow up of a patient with a new de-novo NLRP3 mutation (S595G) and CINCA syndrome.

1 reference

12 December 2020

Localized effects of cAMP mediated by distinct routes of protein kinase A.

1 reference

12 December 2020

Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages

1 reference

12 December 2020

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC

1 reference

12 December 2020

Prostaglandin E(2) couples through EP(4) prostanoid receptors to induce IL-8 production in human colonic epithelial cell lines

1 reference

12 December 2020

The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization

1 reference

12 December 2020

3,4-methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome

1 reference

12 December 2020

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

1 reference

12 December 2020

1 reference

12 December 2020

Epac: defining a new mechanism for cAMP action

1 reference

12 December 2020

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

1 reference

12 December 2020

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

1 reference

12 December 2020

Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome

1 reference

12 December 2020

Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac

1 reference

12 December 2020

New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes

1 reference

12 December 2020

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

1 reference

12 December 2020

Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor

1 reference

12 December 2020

Noncanonical inflammasome activation by intracellular LPS independent of TLR4.

1 reference

12 December 2020

Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin

1 reference

12 December 2020

The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation

1 reference

12 December 2020

Prostaglandins as endogenous mediators of interleukin 1 production

1 reference

12 December 2020

Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis

1 reference

12 December 2020

Non-canonical inflammasome activation targets caspase-11

1 reference

12 December 2020

The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.

1 reference

12 December 2020

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

1 reference

12 December 2020

Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU

1 reference

12 December 2020

Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome

1 reference

12 December 2020

Activation and regulation of the inflammasomes

1 reference

12 December 2020

Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function

1 reference

12 December 2020

The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS).

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNI.3538

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NI.3538

1 reference

6 September 2017

1 reference